The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
John Chan
Honoraria - Abbvie; AstraZeneca; Eisai; Genmab/Seagen; GlaxoSmithKline/Tesaro; Immunogen; Merck; Myriad Genetics; Pfizer
Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Daiichi Sankyo; Eisai; Ethicon; Immunogen; Mersana; moon surgical; Myriad Genetics; Pfizer; Roche/Genentech; Seagen; Tesaro/GSK
Speakers' Bureau - AstraZeneca; Genmab/Seagen; GlaxoSmithKline/Tesaro; Immunogen; Myriad Genetics
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Eisai; Ethicon; Genmab/Seagen; GlaxoSmithKline; Merck; Myriad Genetics; Pfizer
 
Michael Rothe
No Relationships to Disclose
 
Pam Mangat
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Evan Pisick
No Relationships to Disclose
 
Pooja Ghatalia
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Merck (Inst)
 
Andrew Gregory
No Relationships to Disclose
 
Mollie deShazo
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Kathryn Mileham
Consulting or Advisory Role - AstraZeneca; Bayer; Genentech; Merck; Takeda
 
Martina Murphy
Honoraria - IntegrityCE
Consulting or Advisory Role - Abbvie
 
Olatunji Alese
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; Exelixis; GlaxoSmithKline; Ipsen; Loxo/Lilly; Taiho Oncology; Takeda
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - COMPASS THERAPEUTICS, INC
 
Elie Dib
No Relationships to Disclose
 
Peter Kohler
No Relationships to Disclose
 
Justin Moyers
Consulting or Advisory Role - OncLive/MJH Life Sciences; Pfizer; Replimune
Speakers' Bureau - Clinical Care Options; Curio Science
 
Abby Gregory
No Relationships to Disclose
 
Dominique Hinshaw
No Relationships to Disclose
 
Gina Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
 
Richard Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics
Honoraria - Toray Industries; WUGEN, Inc.
Consulting or Advisory Role - Bryologyx; Cellworks; Flatiron Health; Illumina; Veracyte; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Taiho Oncology (Inst)